Five-Year Outcomes and Late Toxicity in Prostate Cancer Patients Treated With Moderate Hypofractionated Helical Tomotherapy and Simultaneous Integrated Boost in a Phase 1-2 Study

To report 5-year outcomes and late toxicity in prostate cancer(PC) patients treated with Helical intensity modulated radiation therapy (IMRT) image guided radiation therapy (IGRT) moderate hypofractionated simultaneous integrated boost (SIB) in a phase 1-2 study. Two hundred eleven PC patients (78 low risk [LR], 53 intermediate risk [IR], and 80 high-risk [HR]) were treated between 2005 and 2011. IR and HR patients received 51.8 Gy on pelvic...